Fig. 5From: Translational strategy using multiple nuclear imaging biomarkers to evaluate target engagement and early therapeutic efficacy of SAR439859, a novel selective estrogen receptor degradera Comparison of fused FLT-PET scans obtained before and during therapy induction. b Quantitative analysis of [18F]-FLT before and 72 h after treatment start with SAR439859 or palbociclib and the combination of the two. Data are expressed as ΔSUV (mean ± SD)Back to article page